Hypertensive rats show increased renal excretion and decreased tissue concentrations of glycine betaine, a protective osmolyte with diuretic properties

PLoS One. 2024 Jan 2;19(1):e0294926. doi: 10.1371/journal.pone.0294926. eCollection 2024.

Abstract

Hypertension leads to water-electrolyte disturbances and end-organ damage. Betaine is an osmolyte protecting cells against electrolyte imbalance and osmotic stress, particularly in the kidneys. This study aimed to evaluate tissue levels and hemodynamic and renal effects of betaine in normotensive and hypertensive rats. Betaine levels were assessed using high-performance liquid chromatography-mass spectrometry (HPLC-MS) in normotensive rats (Wistar-Kyoto, WKYs) and Spontaneously Hypertensive rats (SHRs), a model of genetic hypertension. Acute effects of IV betaine on blood pressure, heart rate, and minute diuresis were evaluated. Gene and protein expression of chosen kidney betaine transporters (SLC6a12 and SLC6a20) were assessed using real-time PCR and Western blot. Compared to normotensive rats, SHRs showed significantly lower concentration of betaine in blood serum, the lungs, liver, and renal medulla. These changes were associated with higher urinary excretion of betaine in SHRs (0.20 ± 0.04 vs. 0.09 ± 0.02 mg/ 24h/ 100g b.w., p = 0.036). In acute experiments, betaine increased diuresis without significantly affecting arterial blood pressure. The diuretic response was greater in SHRs than in WKYs. There were no significant differences in renal expression of betaine transporters between WKYs and SHRs. Increased renal excretion of betaine contributes to decreased concentration of the protective osmolyte in tissues of hypertensive rats. These findings pave the way for studies evaluating a causal relation between depleted betaine and hypertensive organ damage, including kidney injury.

MeSH terms

  • Animals
  • Betaine* / metabolism
  • Betaine* / pharmacology
  • Blood Pressure
  • Diuretics / pharmacology
  • Electrolytes / metabolism
  • Hypertension* / genetics
  • Kidney / metabolism
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Renal Elimination

Substances

  • Betaine
  • Diuretics
  • Electrolytes

Grants and funding

This work was supported by the National Science Centre, Poland: 2018/31/B/NZ5/00038 (MU). The LC/MS-MS equipment was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland. We would like to thank Foundation of Polish Science TEAM TECH CORE FACILITY/2016-2/2 Mass Spectrometry of Biopharmaceuticals - improved methodologies for qualitative, quantitative, and structural characterization of drugs, proteinaceous drug targets and diagnostic molecules. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.